Glaxo, Lilly, Pfizer Said to Eye Stake in Turkey’s MN Pharma

GlaxoSmithKline Plc, Eli Lilly & Co. and Pfizer Inc. are among about half a dozen companies interested in buying a stake in Mustafa Nevzat Ilac Sanayii AS in a deal that may value the Turkish drugmaker at $1 billion, three people with knowledge of the situation said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.